LEARNING OBJECTIVES
The use of inotropes for correcting hemodynamic dysfunction in patients with congestive heart failure has been described over many decades.
However, negative or insufficient data has been collected on the effects of cardiac glycosides, cathecolamines, and phosphodiesthrase inhibitors on quality of life and survival.
More recently, the calcium sensitizer and potassium channel opener levosimendan has been proposed as a safer inodilatorⁱ.
This series of tutorials focuses on how to use levosimendan safely and effectively in acute and advanced heart failure.
Ref. ⁱ Pollesello P et al. Int J Cardiol. 2016;203:543-8
SUNDAY
MONDAY
TUESDAY
EVENT INFORMATION
Location: ESC 2018, Messe Munich International, Munich, Germany, Hall 3, Practical Tutorials 6
More information: https://www.escardio.org/Congresses-&-Events/ESC-Congress
PROGRAM
Practical Tutorials 6
Inotropes in Acute Heart Failure: from guidelines to practical use
10:00 – 10:30 Guidelines and patient characteristics
Alexandre Mebazaa – Paris, France
10:30– 11:00 Therapeutic options and clinical practice
John Parissis – Athens, Greece
Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators?
11:30 – 12:00 Patient characteristics
Veli-Pekka Harjola – Helsinki, Finland
12:00 – 12:30 Therapeutic options and clinical practice
Carsten Tschöpe - Berlin, Germany
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure?
13:00 – 13:30 Cardio-renal syndrome
Finn Gustafsson - Copenhagen, Denmark
13:30 – 14:00 Therapeutic options and clinical practice Simon Matskeplishvili - Moscow, Russia
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
14:30 – 15:00 What is available?
Zoltán Papp – Debrecen, Hungary
15:00 – 15:30 Therapeutic options and clinical practice
Attila Borbély - Debrecen, Hungary
Repetitive use of inodilators in Advanced Heart Failure
16:00 – 16:30 Patient characteristics
Francesco Fedele - Rome, Italy
16:30 – 17:00 Therapeutic options and clinical practice
Fabrizio Oliva – Milan, Italy
Practical Tutorials 6
Inotropes in Acute Heart Failure: from guidelines to practical use
10:00 – 10:30 Guidelines and patient characteristics
Friedrich Fruhwald – Graz, Austria
10:30 – 11:00 Therapeutic options and clinical practice
Dirk von Lewinski – Graz, Austria
Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators?
11:30 – 12:00 Patient characteristics
Veli-Pekka Harjola – Helsinki, Finland
12:00 – 12:30 Therapeutic options and clinical practice
Carsten Tschöpe - Berlin, Germany
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure?
13:00 – 13:30 Cardio-renal syndrome
Finn Gustafsson - Copenhagen, Denmark
13:30 – 14:00 Therapeutic options and clinical practice
Simon Matskeplishvili - Moscow, Russia
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
14:30 – 15:00 What is available?
George Giannakoulas – Thessaloniki, Greece
15:00 – 15:30 Therapeutic options and clinical practice
Robert H Schwinger – Weiden, Germany
Repetitive use of inodilators in Advanced Heart Failure
16:00 – 16:30 Patient characteristics
Josep Comin-Colet – Barcelona, Spain
16:30 – 17:00 Therapeutic options and clinical practice
Gerhard Pölzl - Innsbruck, Austria
Practical Tutorials 6
Inotropes in Acute Heart Failure: from guidelines to practical use
10:00 – 10:30 Guidelines and patient characteristics
Friedrich Fruhwald – Graz, Austria
10:30 – 11:00 Therapeutic options and clinical practice
Dirk von Lewinski – Graz, Austria
Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators?
11:30 – 12:00 Patient characteristics
Matti Kivikko – Espoo, Finland
12:00 – 12:30 Therapeutic options and clinical practice
John Parissis – Athens, Greece
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure?
13:00 – 13:30 Cardio-renal syndrome
Francesco Fedele - Rome, Italy
13:30 – 14:00 Therapeutic options and clinical practice
Fabrizio Oliva – Milan, Italy
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
14:30 – 15:00 What is available?
Zoltán Papp – Debrecen, Hungary
15:00 – 15:30 Therapeutic options and clinical practice
Attila Borbély - Debrecen, Hungary
Repetitive use of inodilators in Advanced Heart Failure
16:00 – 16:30 Patient characteristics
Josep Comin-Colet – Barcelona, Spain
16:30 – 17:00 Therapeutic options and clinical practice
Gerhard Pölzl - Innsbruck, Austria
